Back
CytoMed Therapeutics Ltd. Stock Price Chart
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist Now
Sell
29
GDTC
CytoMed Therapeutics Ltd.
Last Price:
$1.88
Seasonality Move:
-6.92%
7 Day Trial
ALL ACCESS PASS
$
7
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist Now-
The current trend is relatively stagnant and GDTC is experiencing slight buying pressure.
CytoMed Therapeutics Ltd. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.82 | Sell |
| 20-day SMA: | 1.88 | Sell |
| 50-day SMA: | 2.07 | Sell |
| 200-day SMA: | 2.18 | Sell |
| 8-day EMA: | 1.82 | Sell |
| 20-day EMA: | 1.89 | Sell |
| 50-day EMA: | 1.99 | Sell |
| 200-day EMA: | 2.13 | Sell |
CytoMed Therapeutics Ltd. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 39.81 | Sell |
| Chaikin Money Flow: | 3886 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.81 - 2.03) | Sell |
| Bollinger Bands (100): | (1.79 - 2.19) | Sell |
CytoMed Therapeutics Ltd. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CytoMed Therapeutics Ltd. Stock
Is CytoMed Therapeutics Ltd. Stock a Buy?
-
CytoMed Therapeutics Ltd. share price is 1.77 while GDTC 8-day simple moving average is 1.82, which is a Sell signal.
-
The stock price of GDTC is 1.77 while CytoMed Therapeutics Ltd. 20-day SMA is 1.88, which makes it a Sell.
-
CytoMed Therapeutics Ltd. 50-day simple moving average is 2.07 while GDTC share price is 1.77, making it a Sell technically.
-
GDTC stock price is 1.77 and CytoMed Therapeutics Ltd. 200-day simple moving average is 2.18, creating a Sell signal.
GDTC Technical Analysis vs Fundamental Analysis
Sell
29
CytoMed Therapeutics Ltd. (GDTC)
is a Sell
Is CytoMed Therapeutics Ltd. a Buy or a Sell?
-
CytoMed Therapeutics Ltd. stock is rated a SellThe current CytoMed Therapeutics Ltd. [GDTC] share price is $1.77. The Score for GDTC is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
CytoMed Therapeutics Ltd. Stock Info
Market Cap:
20.8M
Price in USD:
1.77
Share Volume:
11.6K
CytoMed Therapeutics Ltd. 52-Week Range
52-Week High:
4.05
52-Week Low:
1.65
Sell
29
CytoMed Therapeutics Ltd. (GDTC)
is a Sell
CytoMed Therapeutics Ltd. Share Price Forecast
-
What is the CytoMed Therapeutics Ltd. stock price today?The CytoMed Therapeutics Ltd. stock price is 1.77 USD today.
-
Will GDTC stock go up or go down?CytoMed Therapeutics Ltd.> share price is forecast to RISE/FALL based on technical indicators
-
Is CytoMed Therapeutics Ltd. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CytoMed Therapeutics Ltd. is overvalued.
Is CytoMed Therapeutics Ltd. Stock a Buy?
-
CytoMed Therapeutics Ltd. share price is 1.77 while GDTC 8-day exponential moving average is 1.82, which is a Sell signal.
-
The stock price of GDTC is 1.77 while CytoMed Therapeutics Ltd. 20-day EMA is 1.89, which makes it a Sell.
-
CytoMed Therapeutics Ltd. 50-day exponential moving average is 1.99 while GDTC share price is 1.77, making it a Sell technically.
-
GDTC stock price is 1.77 and CytoMed Therapeutics Ltd. 200-day simple moving average is 2.13, creating a Sell signal.
Fundamental Analysis of CytoMed Therapeutics Ltd.
Is CytoMed Therapeutics Ltd. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.00 per share.
Technical Analysis of CytoMed Therapeutics Ltd.
Should I short CytoMed Therapeutics Ltd. stock?
-
GDTC Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting CytoMed Therapeutics Ltd. is a Sell
-
CytoMed Therapeutics Ltd. Relative Strength Index (RSI) is 39.81, which suggest CytoMed Therapeutics Ltd. is oversold
-
The Bollinger Bands (25) for CytoMed Therapeutics Ltd. is (1.81 - 2.03), which suggest CytoMed Therapeutics Ltd. is a Sell
-
The Bollinger Bands (100) for CytoMed Therapeutics Ltd. is (1.79 - 2.19), which suggest CytoMed Therapeutics Ltd. is a Sell
* CytoMed Therapeutics Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.